By Ricardo Alonso-Zaldivar, Associated Press Writer
WASHINGTON (AP) — Seniors with high drug costs will soon have more options to help them cope with Medicare's prescription coverage gap.
Reversing a steady decline, the number of prescription plans covering at least some brand-name drugs in the "doughnut hole" coverage gap will triple next year, from 35 to 106. That's according to an analysis of Medicare data to be released Wednesday by Avalere Health, a private research firm.
At least two plans covering some brand-name drugs in the gap will be available in every region of the country.
The enhanced coverage carries a higher monthly premium. And the plans offer only a limited range of medications in the gap, most often drugs to treat chronic illnesses.
Nonetheless, some seniors may be willing to pay more for greater peace of mind. Some of the most widely used medications, including Lipitor for high cholesterol, are not available as generics.
"The coverage of generics in the gap has been fairly stable, but there has been very little coverage of brand-name drugs," said Bonnie Washington, an Avalere researcher who worked on the study. "This is the first year we have really seen it come back."
The coverage expansion is partly the result of prodding by Medicare officials to get private insurers to offer more robust plans, Washington said.
Medicare's drug coverage gap is a cost-control idea that has never been popular.
In 2011, the gap will start after Medicare beneficiaries and their insurance plan have spent $2,840 on medications.